|
| |
Image Results
Loading...
Loading...
FACTIVE Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
NDA 21-158 Factive® (gemifloxacin mesylate) Class of Product ...
Each Factive package will contain a tear-off Medication Guide from the Package ... prescription for Factive. The label of each container or package of ...
http://www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrug...
|
FACTIVE (gemifloxacin mesylate) tablet [Oscient Pharmaceuticals ...
Fluoroquinolones, including FACTIVE®, are associated with an increased risk of tendinitis and tendon rupture in all ages. This risk is further increased in ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=8345...
|
MEDICATION GUIDE FACTIVE [FAC-tiv] (gemifloxacin) 320mg Tablets ...
Read the Medication Guide that comes with FACTIVE before you start taking it ... See the list of ingredients in FACTIVE at the end of this Medication Guide. ...
http://www.fda.gov/downloads/Drugs/DrugSafety/UCM152723.pdf...
|
FDA Safety Labeling Changes: Sarafem, Tequin, Factive
15 Dec 2004 ... The FDA has approved revisions to the safety labeling for fluoxetine (Sarafem), gatifloxacin (Tequin), and gemifloxacin mesylate (Factive).
http://www.medscape.com/viewarticle/496044...
|
Factive (gemifloxacin mesylate)
11 Jul 2009 ... “new safety information” with the use of Factive, particularly the increased risks of tendonitis and tendon rupture. ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-...
|
Discovery of gemifloxacin (Factive, LB20304a): a quinolone of a ...
Among these compounds our development candidate, Gemifloxacin (Factive, LB20304a ), showed the best in vivo efficacy and pharmacokinetic profile in animals, ...
http://www.ncbi.nlm.nih.gov/pubmed/11347965...
|
Factive (gemifloxacin mesylate) Tablets
12 Jul 2009 ... WARNING: Fluoroquinolones, including Factive, are associated with an increased risk of tendinitis and tendon rupture in all ages. ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-...
|
Oscient Pharmaceuticals Corporation Amends FACTIVE License ...
In addition, the amendment restructures the economic terms relating to sales of FACTIVE in Europe, including a reduction in royalty rates on future sales to ...
http://www.biospace.com/news_story.aspx?NewsEntityId=41256...
|
News: New Treatment Guidelines for Community-Acquired Pneumonia ...
22 Feb 2007 ... FACTIVE is approved in the U.S. for the seven-day treatment of mild to moderate CAP, ... Important Safety Information about FACTIVE Table ...
http://www.genengnews.com/news/bnitem.aspx?name=13223926...
|
{1} Release: FACTIVE, Gemifloxacin Mesylate, Tablets Receive ...
(Nasdaq: GENE - News) has received marketing approval for FACTIVE® (gemifloxacin mesylate) tablets for the treatment of acute bacterial exacerbations of ...
http://www.biospace.com/news_story.aspx?NewsEntityId=1542292...
|
|